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Background: Mucus hypersecretion contributes to the morbidity and mortality of smoking-related lung diseases,
especially chronic obstructive pulmonary disease (COPD), which starts in the small airways. Despite progress in
animal studies, the genes and their expression pattern involved in mucus production and secretion in human
airway epithelium are not well understood. We hypothesized that comparison of the transcriptomes of the small
airway epithelium of individuals that express high vs low levels of MUC5AC, the major macromolecular component
of airway mucus, could be used as a probe to identify the genes related to human small airway mucus production/
secretion.
Methods: Flexible bronchoscopy and brushing were used to obtain small airway epithelium (10th to 12th order
bronchi) from healthy nonsmokers (n=60) and healthy smokers (n=72). Affymetrix HG-U133 plus 2.0 microarrays
were used to assess gene expression. Massive parallel sequencing (RNA-Seq) was used to verify gene expression of
small airway epithelium from 5 nonsmokers and 6 smokers.
Results: MUC5AC expression varied 31-fold among the healthy nonsmokers. Genome-wide comparison between
healthy nonsmokers (n = 60) grouped as “high MUC5AC expressors” vs “low MUC5AC expressors” identified 528
genes significantly up-regulated and 15 genes significantly down-regulated in the high vs low expressors. This
strategy identified both mucus production and secretion related genes under control of a network composed of
multiple transcription factors. Based on the literature, genes in the up-regulated list were used to identify a 73
“MUC5AC-associated core gene” list with 9 categories: mucus component; mucus-producing cell differentiation-
related transcription factor; mucus-producing cell differentiation-related pathway or mediator; post-translational
modification of mucin; vesicle transport; endoplasmic reticulum stress-related; secretory granule-associated; mucus
secretion-related regulator and mucus hypersecretory-related ion channel. As a validation cohort, we assessed the
MUC5AC-associated core gene list in the small airway epithelium of an independent set of healthy smokers (n = 72).
There was up-regulation of MUC5AC in the small airway epithelium of smokers (2.3-fold, p< 10-8) associated with a
coordinated up-regulation of MUC5AC-associated core gene expression pattern in the small airway epithelium of
smokers (p< 0.01). Deep sequencing confirmed these observations.
Conclusion: The identification of the genes associated with increased airway mucin production in humans should
be useful in understanding the pathogenesis of airway mucus hypersecretion and identifying therapeutic targets.* Correspondence: geneticmedicine@med.cornell.edu
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Mucus hypersecretion contributes to the morbidity and mortality of smoking-related lung diseases, especially
chronic obstructive pulmonary disease (COPD), which starts in the small airways. Little is known about the gene
networks associated with the synthesis and secretion of mucins in the human small airway epithelium. Taking
advantage of the knowledge that MUC5AC is a major mucin secreted by the small airway epithelium, the expression
of MUC5AC in small airway epithelium is highly regulated at the transcriptional level and our observation that
healthy nonsmokers have variable numbers of MUC5AC+ secretory cells in the human small airway epithelium, we
compared genome-wide gene expression of the small airway epithelium of high vs low MUC5AC expressors from 60
nonsmokers to identify the genes associated with MUC5AC expression. This novel strategy enabled identification of
a 73 “MUC5AC-associated core gene” list with 9 categories, which control a series of processes from mucin
biosynthesis to mucus secretion. The coordinated gene expression pattern of MUC5AC-associated core genes were
corroborated in an independent cohort of 72 healthy smokers. Deep sequencing of small airway epithelium RNA
confirmed these observations. This finding will be useful in identifying therapeutic targets to treat small airway
mucus hypersecretion.Background
The process of mucus production and secretion is central
to the normal defense of the lung, with mucus an important
component of the airway mucociliary escalator that con-
tinuously cleanses the lung of inhaled particulates, patho-
gens and xenobiotics [1]. Mucus is comprised of several
components, but is dominated by the secretory mucins:
high molecular weight, disulfide linked, heavily glycosylated
proteins [2]. There has been considerable progress in defin-
ing the mucin composition of airway mucus in health and
disease [3], and regulation of mucin synthesis and secretion
in the mouse lung [4-9]. However, little is known about the
gene networks associated with the synthesis and secretion
of mucins in the human small airway epithelium, the cell
population exhibiting the first abnormalities associated with
smoking [10-14], and the major site of pathology in chronic
obstructive pulmonary disease (COPD) [13,15].
One successful approach to understanding mucin syn-
thesis/secretion in the human lung has been to use infor-
mation from gene manipulation in murine models to
identify genes associated with mucin synthesis/secretion,
and to evaluate these genes and their associated genes in
samples of human airways or in air-liquid interface cul-
tures of human airway epithelium [3-9,16-22]. In order to
expand this knowledge base on a genome wide level, we
have developed a novel strategy to define the network of
genes linked to MUC5AC expression in the human small
airway epithelium. Our approach is based on the under-
standing that there are no mucus glands in the small air-
ways of humans, and the secretory mucins are produced
solely by surface secretory cells [1]. Taking advantage of
the knowledge that MUC5AC is a major mucin secreted
by the small airway epithelium, the expression of
MUC5AC in small airway epithelium is highly regulated at
the transcriptional level [17] and our observation that
healthy nonsmokers have variable numbers of MUC5AC+
secretory cells in the human small airway epithelium, wehypothesized that we could group healthy nonsmokers
into small airway epithelium “high” and “low”.
MUC5AC expressors. With this strategy, we compared
genome-wide gene expression of the small airway epi-
thelium of high vs low MUC5AC expressors to identify
the genes associated with MUC5AC expression. Anno-
tating this list of genes with the literature relating to
mucus production/secretion enabled identification of a
small airway epithelium “MUC5AC-associated core
gene” list. As a validation strategy for the MUC5AC-
associated core gene list, based on the knowledge that
cigarette smoking is an environmental stressor asso-
ciated with increased mucus production [1-3,17,18,
22,23], we assessed MUC5AC and MUC5AC-associated
core gene expression in an independent cohort of
healthy smokers. Not only was MUC5AC up-regulated
in the smoker small airway epithelium, but many of the
MUC5AC-associated core genes were as well, confirm-
ing the validity of the core gene list as being co-
regulated with MUC5AC expression.
Results
MUC5AC expression in the small airway epithelium of
healthy nonsmokers
Consistent with prior studies of airway mucin gene ex-
pression in humans [2,3], only 3 types of mucins (secre-
tion-polymeric, tethered-shed in mucus and tethered)
were expressed (P call % >80%) in the small airway epi-
thelium (Table 1). Among these 8 mucin genes, we fo-
cused on MUC5AC (214385_s_at), a secreted-polymeric
mucin, as it is highly expressed by airway surface
mucus-producing cells [2,3,18].
To assess the proportion of MUC5AC positive cells in
the small airway epithelium, MUC5AC staining was car-
ried out on cytospin slides prepared from 10-12th order
brushed airway epithelial cells from healthy nonsmokers
(Figure 1). Consistent with the literature [24,25], there
Table 1 Mucin gene expression in small airway
epithelium of healthy nonsmokers




MUC7 217059_at 0 N/A3
MUC8 217295_at 0 N/A
Secreted,
polymeric
MUC6 214133_at 8 N/A
MUC19 1553436_at 0 N/A
MUC2 204673_at 25 N/A
MUC5AC 214385_s_at 100 54 ± 44
MUC5B 213432_at 100 48 ± 29
Tethered, shed
in mucus
MUC1 213693_s_at 100 70 ± 18
MUC16 220196_at 100 46 ± 18
MUC4 217109_at 100 81 ± 36
Tethered MUC12 226654_at 6 N/A
MUC13 218687_s_at 100 5 ± 4
MUC15 227238_at 100 65 ± 18
MUC17 232321_at 0 N/A
MUC20 226622_at 100 46 ± 23
MUC3A 217117_x_at 50 N/A
MUC3B 214898_x_at 2 N/A
1 If one gene had multiple probe sets, the one with highest % P was used.
2 Gene expression data was normalized “per chip” in Genespring 7.0, which is
normalized to the median expression level of all the genes on the chip. Data is
expressed as mean ± standard deviation.
3 N/A, the expression is not shown because % P< 80%.
Figure 1 Variability of proportions of surface MUC5AC+ cells in
the small airway epithelium of healthy nonsmokers.
Immunofluorescence of MUC5AC staining (red) was processed on
cytospin slides prepared from 10th-12th order brushed airway
epithelial cells. Shown are examples from 6 individuals. Not shown,
IgG irrelevant control, negative for MUC5AC staining. Blue - DAPI.
Bar = 20 μm.
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lium of healthy nonsmokers. Importantly, relevant to the
present study, there was significant variability from indi-
vidual to individual in the number of MUC5AC positive
cells. In agreement with the histologic findings, healthy
nonsmokers showed significant variation in the degree
of MUC5AC gene expression. Compared to the house-
keeping genes ACTB (CV= 23.9%), GAPDH (CV=
38.1%,), B2M (CV= 15.2%), RPLP0 (CV= 23.0%) and
PPIA (CV= 31.4%), the variability of MUC5AC was >2-
fold higher (CV= 81.6%; Figure 2; Ansari-Bradley test,
p< 10-8, all comparisons).
Identification of MUC5AC-associated core genes
In order to identify genes associated with MUC5AC bio-
synthesis and secretion, we compared the gene expres-
sion differences between healthy nonsmoker high
MUC5AC expressors vs low MUC5AC expressors. To
avoid confusion of the dominant transcriptome response
to oxidative stress in smokers, only nonsmokers were
used to identify genes associated with MUC5AC expres-
sion. After controlling false discovery rate by Benjamini-
Hochberg correction (p< 0.05), microarray analysis
revealed 528 genes were up-regulated and 15 genes weredown-regulated in MUC5AC high expressors compared
to the MUC5AC low expressors (Figure 3; Additional
file 1: Table S2).
To explore the function of the up-regulated genes, the
online annotation term enrichment tool, DAVID, was
used. Genes with functional annotation of Golgi (p< 10-9),
endoplasmic reticulum (ER; p< 10-5), and ER-Golgi
transport (p< 2x10-4) were enriched in these genes
(Additional file 1: Table S3). This is consistent with
the knowledge that Golgi, ER apparatus, and transport
between ER and Golgi are essential to the secretion path-
way [26]. Based on these associations, further literature
mining was carried out to identify which genes were
known to be associated with or potentially involved in
mucus production or secretion.
From 528 up-regulated genes, we found 73 genes with
literature supported roles or potential roles in mucus
production/secretion. The putative roles of these 73
“MUC5AC-core genes” were grouped into 9 categories:
(1) mucus components; (2) mucus-producing cell
differentiation-related transcription factors; (3) mucus-
producing cell differentiation-related pathways or media-
tors; (4) post-translational modification of mucin; (5)
-2-4-8-16 1 16842
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Figure 3 Identification of MUC5AC-associated core genes. Shown is
a volcano plot comparing the normalized expression of gene probe sets
in the 10-12th order brushed airway epithelial cells of nonsmoker-high
MUC5AC expressors vs low MUC5AC expressors; y-axis - negative log of
p value; x-axis - log2-transformed fold-change; red dots - probe sets with
significant p value; blue dots - probe sets with non-significant p value.
Differentially expressed genes were determined by unequal variance
Student’s t-test followed by Benjamini-Hochberg correction (p< 0.05).
There were 528 genes identified genome-wide that were significantly
correlated with MUC5AC high expressors. Of these, 73 genes were
identified as MUC5AC-associated core genes based on literature mining




































23.9% 38.1% 15.2% 23.0% 31.4%
Figure 2 Healthy nonsmokers were grouped based on MUC5AC
gene expression in 10-12th order brushed airway epithelial
cells. Shown is data for n = 60 nonsmokers divided into nonsmoker
“high MUC5AC expressors” (MUC5AC expression, highest quartile of
all healthy nonsmokers, n = 15, upper shaded region) and
nonsmoker “low MUC5AC expressors” (MUC5AC expression, lowest
quartile of all healthy non-smokers, n = 15, lower shaded region).
Expression of 5 endogenous control genes (ACTB, GAPDH, B2M,
RPLP0 and PPIA) in the same samples are used as controls to assess
the expression variability in nonsmokers of housekeeping genes
compared to MUC5AC. The coefficients of variation (CV) of MUC5AC
and endogenous control gene expression are shown.
Wang et al. BMC Medical Genomics 2012, 5:21 Page 4 of 16
http://www.biomedcentral.com/1755-8794/5/21vesicle transport; (6) endoplasmic reticulum stress-related;
(7) secretory granule-associated; (8) mucus secretion-
related regulators and (9) mucus hypersecretory-related
ion channels (Table 2; see Additional file 1: Table S1 for
all related references; see Additional file 1: Figure S1, S2
for the likely roles of the products of these genes in airway
mucus production and secretion). Within each category,
the literature regarding the relevance of each gene to small
airway epithelial MUC5AC production and secretion were
catalogued as to links in the literature based on non-
human models, human cells in vitro, human airway epi-
thelium in vivo and “functional association”, i.e., likely
function in the airway epithelium based on the known
function of the gene product.
From the assignments based on the literature, 27 of the
73 MUC5AC-core genes have been previously identified
as being associated with mucus production or secretion,
including those associated with mucus components
(TFF3, TFF1); mucus-producing cell differentiation
related-transcription factors (SPDEF, FOXA3, SOX2 and
KLF4); mucus-producing cell differentiation-related path-
ways or mediators (HES1 and TSTA3, Notch pathway;
RPS6KA3 and KRAS, MAPK pathway; PLA2G4A; CTSC;
SERPINB4); post-translational modification of mucin
(AGR2, GNE, GALNT4, GALNT7, GALNT12); secretorygranule-associated (SYTL2, RAB27B, RAB3D, SCIN,
MYO5B, MYO5C); mucus secretion-related regulators
(ITPR3, PRKCD); and a mucus hypersecretory-related
ion channel (SLC12A2). Of these 27 MUC5AC-core
genes known to be strongly linked to mucus produc-
tion and secretion, most have been linked to airway
mucus production and secretion by murine or
in vitro studies; only 9 have been previously linked to
MUC5AC production/secretion in human in vivo
studies (Additional file 1: Table S1).
Of the remaining 46 MUC5AC-core genes, although
they have not been strongly linked to airway mucus pro-
duction/secretion, there is literature supporting their
roles in mucus production/secretion in other cell types,
including mucus-producing cell differentiation-related
pathways or mediators (Wnt pathway gene, LRRFIP2
and MAPK pathway gene, MAPK13); post-translational
modification of mucin (FUT3, FUT6, ST6GAL1,
ST8SIA1, CHST6, GALNT5, GALNT6); vesicle trans-
port (MIA3, SURF4, KDELR2, KDELR3, ITSN1,
ERGIC1, CKAP4, GOSR1, SYNJ2BP, MPPE1, SEC31A,
ARF4, VPS13D, SEC22B and TPD52); ER stress-related
(EIF2AK3, EDEM3, XBP1 and CREB3L1); secretory






























TFF3 SPDEF HES1 AGR2 MIA3 CREB3L1 SYTL2 PRSS23 SLC12A2
TFF1 FOXA3 TSTA3 GNE SURF4 EDEM3 RAB3D PLCE1 CLCA2
SOX2 LRRFIP2 GALNT4 KDELR2 XBP1 SCIN DGKA SCNN1A
KLF4 KRAS GALNT7 KDELR3 EIF2AK3 STXBP6 ITPR3 GABRP
MAPK13 GALNT12 ITSN1 RAB27B PRKCD
RPS6KA3 PDIA5 ERGIC1 SYTL4
CTSC FUT3 CKAP4 SYTL5
SERPINB4 FUT6 GOSR1 GSN









1 Genes with a role in mucus production or mucus secretion (based on the literature) were selected from the significantly up-regulated genes in nonsmoker
high-MUC5AC expressors compared to nonsmoker low-MUC5AC expressors (see Supplemental Methods for complete criteria).
2 References for the functions of each gene are in Additional file 1: Table S1. See Additional file 1: Figure S1, S2 for the schematic illustration of the functions of
these genes relevant to MUC5AC-production/secretion.
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KIF5B, CDC42EP5); mucus secretion-related regulators
(PRSS23, DGKA, PLCE1); and mucus hypersecretory-
related ion channels (CLCA2, SCNN1B and GABAP)
(Table 2, Additional file 1: Table S1).
Together, the MUC5AC-core genes suggest that mul-
tiple molecular events involving the nucleus, endoplas-
mic reticulum, Golgi, vesicles and plasma membrane
work coordinately in the human small airway epithelium
to promote mucus production and secretion in
MUC5AC-producing cells.
MUC5AC-core genes in smokers
Chronic cigarette smoking, with its 4000 xenobiotics
and >1014 oxidants per puff, is a complicated stress to
the airway epithelium of smokers [22,27]. Based on this,
and the knowledge that smoking induces metaplasia of
MUC5AC positive cells in the airway epithelium [1-
3,22], and prior literature detailing increased expression
of MUC5AC in the airway epithelium of smokers
[3,28,29], we used small airway epithelium of chronic
smokers as a validation set, i.e., if the human MUC5AC-
core genes identified in the nonsmoker small airway
epithelium are truly associated with MUC5AC synthesis/
secretion, then the MUC5AC-core genes should be up-
regulated in the small airway epithelium of smokers. Asexpected, healthy smokers had 2.3-fold higher MUC5AC
gene expression than nonsmokers (Figure 4A). Like
the nonsmokers, there was considerable variability in
MUC5AC expression among smokers [MUC5AC
coefficient of variation among smokers 47.1%, compared
to 25.3 ± 3.1% for the 5 housekeeping genes, ACTB,
GAPDH, B2M, RPLP0 and PPIA (Ansari-Bradley test, all
p< 10-11 for comparison between MUC5AC and each
housekeeping gene)]. Comparison of the expression pat-
terns of MUC5AC-core genes between healthy smokers
and healthy nonsmokers demonstrated that 28 of the 73
(38%) MUC5AC-core genes were up-regulated in
smokers (Figure 4B, Additional file 1: Table S4). Interest-
ingly, 6 out of the 73 MUC5AC-core genes were down-
regulated by smoking, suggesting smoking has a variable
effect on some components of the orchestrated
MUC5AC-production/secretion system in the small air-
way epithelium.
To assess these global smoking-related modifications of
the MUC5AC core genes, we created an overall index of
the MUC5AC-core genes. The index analysis supported
the concept that healthy smokers had more active
MUC5AC-core gene expression (up- or down-regulation)
compared to the nonsmokers (p< 0.01, Figure 4C).
Clustering analysis comparing the high and low MUC5AC



































































































Figure 4 cMUC5AC expression and MUC5AC-core genes in the small airway epithelium of healthy smokers. A. MUC5AC gene expression
distribution in healthy smokers (blue, n = 60) compared to healthy nonsmokers (red, n = 72). Y-axis, number of subjects; X-axis, normalized
MUC5AC expression. B. Volcano plot of MUC5AC-core genes comparing healthy smokers and healthy nonsmokers. Differentially expressed genes
between smokers (n = 72) and nonsmokers (n = 60) were determined by unequal variance Student’s t-test followed by Benjamini-Hochberg
correction (p< 0.05). Only MUC5AC-core genes were plotted. y-axis - negative log of p value; x-axis - log2-transformed fold-change; red dots –
smoking up-regulated MUC5AC-core genes; blue dots – smoking down-regulated MUC5AC-core genes; grey dots – smoking unchanged
MUC5AC-core genes. Numbers of each group are shown. C. Index of expression of the MUC5AC-core genes (% of abnormally expressed
MUC5AC-core genes beyond that of healthy nonsmoker MUC5AC low-expressors in healthy nonsmokers (blue) compared to healthy smokers
(red). Fold-change represents the average index difference between the groups, p value indicates significant differences between the groups.
D. Unsupervised hierarchical clustering analysis of expression of MUC5AC-core genes in nonsmoker-high MUC5AC expressors (black, highest
quartile of all healthy non-smokers, n = 15), nonsmoker-low MUC5AC expressors (green, lowest quartile of all healthy non-smokers, n = 15),
smoker-high MUC5AC expressors (red, highest quartile of all healthy smokers, n = 18) and smoker-low MUC5AC expressors (blue, lowest quartile
of all healthy smokers, n = 18). Genes expressed above the average are represented in red, below average in blue, and average in white.
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kers and nonsmokers, based on expression of the
MUC5AC-core genes, with nonsmoker-high MUC5AC
expressors having a similar expression pattern of
MUC5AC-core genes to smoker-high MUC5AC expres-
sors (Figure 4D). Together, these results suggest that most
MUC5AC-core genes are shared by smokers and nonsmo-
kers in association with high MUC5AC expression.To confirm the microarray findings, RNA sequencing
was used to assess the gene expression profile from airway
epithelium of 5 nonsmokers and 6 smokers. Consistent
with microarray data, RNA-Seq data showed that
MUC5AC-core genes had a coordinated expression pattern
(Figure 5). As with the microarray data, in general, smokers
had more active MUC5AC-core gene expression, although
similar to the microarray data, there was overlap, with some
102435805264465228952 79974083194258350 4252













Figure 5 MUC5AC-core genes assessed by RNA-Seq analysis in healthy smokers and healthy nonsmokers. Shown is a hierarchical cluster
analysis of RNA-Seq data of expression of the MUC5AC-associated core genes from 5 healthy nonsmokers and 6 healthy smokers. Smoking status
was represented by different colors (nonsmoker, blue; smoker, brown). In the heat map, gene expression above the average is represented in red,
below average in blue, and average in white. The color schemes represent the relative expression level across each row (each gene). Dendrogram
color denotes there are two different groups independent of smoking status. The expression level (RPKM) of MUC5AC is shown under the label
of each individual (NS = nonsmoker; S = smoker).
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MUC5AC-core genes in asthma
Asthma is known to be associated with airway mucus
overproduction. To assess the effect of asthma on
MUC5AC-core gene expression, the data set from a
study by Woodruff et al. [30] was used. Comparison ofthe expression patterns of MUC5AC-core genes between
asthma patients at baseline and healthy nonsmokers
demonstrated that 6 of the 73 (8%) MUC5AC-core genes
were up-regulated and 1 MUC5AC-core gene was
down-regulated in asthma (Additional file 1: Table S6).
To assess whether expression of MUC5AC-core genes
were correlated with MUC5AC in this asthma study, we
performed genome-wide correlation analysis to
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MUC5AC-core genes are among the top 300 genes
correlated with MUC5AC (p< 10-4, Additional file 1:
Table S7).
Gene networks linking the MUC5AC-core genes
To help understand the underlying mechanism of the
coordinate expression of the MUC5AC-core genes, a
gene network was built with the focus on transcrip-
tional control. Based on the knowledge from murine
studies or in vitro studies that inhibition of the tran-
scription factors Spdef, Sox2 and Klf4 or perturbation of












Figure 6 Proposed gene network of the MUC5AC-core genes. From th
connection to other MUC5AC-core genes were selected (see Methods for d
is affected by the other gene; the data is derived from literature with in vit
transgenic mice data (see Additional file 1: Table S5 for references). Protein
circle include, transcription factors (SPDEF, SOX2, KLF4) and the Wnt, Notch
differentiation. A red dashed circle was used to emphasize their important
MUC5AC-core gene list with literature supported potential role in MUC5AC
factors in the MUC5AC-core gene list. Arrows indicate upstream gene can
data [31], KLF4 can affect mucus-producing cell differentiation, but there is
solid line linked to pathway indicates that MAPK13, KRAS and RPS6KA3 bel
LRRFIP2 belong to “Wnt pathway”. The “T” like symbol indicates a potentialof mucus-producing cells or expression of MUC5AC
[4-9,31], these genes were used as the backbone of the
network (Figure 6). We manually screened each of 73
human small airway MUC5AC-core genes for their
transcriptional connections with other MUC5AC-core
genes. Only those genes with connections with other
MUC5AC-core genes were integrated into the network.
These known interactions among MUC5AC-core genes
suggest that the findings based on the comparison be-
tween high and low MUC5AC expressors were not just
by chance. The network was centered on MUC5AC,
but, interestingly, involved multiple transcription factors

















e MUC5AC-core gene list, genes with at least one literature supported
etail). The connection denotes that the expression level of one gene
ro gene overexpression/activation/knockdown experiments or
to protein interactions are not included. Genes in the brown solid
, MAPK pathways, which can affect MUC5AC-producing cell
roles. Genes in green solid circle represent transcription factors in the
-producing cells. Genes in green rectangles represent non-transcription
regulate downstream gene expression. Dashed arrow, based on mouse
no direct evidence showing KLF4 can affect MUC5AC expression. The
ong to “MAPK pathway”; HES1 and TSTA3 belong to “Notch pathway”;
blocking effect.
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steps of mucus production, which imply the coordi-
nated expression patterns of MUC5AC-core genes are
orchestrated by these transcription factors or pathways.
Notably, SPDEF and CREB3L1 seem to be two major
“driving forces” in this network. The gene network also
provides clues to understand the function of other
MUC5AC-associated genes in mucus production.
The EGF receptor family related signaling pathway
plays an import role in mucus production [32]. However,
our approach to identify MUC5AC-core genes did not
identify EGF receptor family genes as MUC5AC-
associated genes. Interestingly, overexpression of EGF
receptor 2 (ERBB2, HER2) has been demonstrated in
primary lung mucinous adenocarcinomas, which were
characterized by KRAS activating mutations as well as
very high levels of MUC5AC production [33,34]. To in-
vestigate the possible relation between ERBB2 and
MUC5AC at the transcriptome level, we performed
genome-wide correlation analysis for ERBB2 in both
healthy nonsmokers and healthy smokers. Although
EGF receptor-associated pathways were enriched in
ERBB2 correlated genes (Additional file 1: Table S8), no
close relation between ERBB2 and mucus production-
related genes were found.
Discussion
Mucus hypersecretion is a cardinal feature of chronic
airway diseases and mucins are the major component of
airway mucus [1-4,17,18,23]. Despite the significant pro-
gress in understanding the transcriptional control, bio-
synthesis and secretion of mucins using murine models,
advances in understanding the coordinated gene expres-
sion relevant to producing and secreting mucins in the
human airway have been limited due to the lack of
methods to isolate and culture pure populations of pri-
mary human airway mucin-producing cells. Taking ad-
vantage of the knowledge that MUC5AC is the major
secreted mucin of the small airway epithelium, and our
observation that there is variable small airway epithelium
MUC5AC expression among healthy nonsmokers, we
hypothesized that genome-wide comparison of small air-
way gene expression of healthy individuals with “high”
MUC5AC expression to those with “low” MUC5AC ex-
pression would identify genes whose regulation paral-
leled that of MUC5AC.
From a list of 528 genes up-regulated in healthy high
MUC5AC expressors compared to healthy low
MUC5AC expressors, we identified 73 MUC5AC core
genes that had literature support for a role in mucin
production/secretion, from murine studies of the air-
ways, immunohistochemical or in situ hybridization
studies of human airway epithelium, studies from
mucin-secreting cell lines, or studies relating to mucinproduction/secretion in organs other than lung. These
genes included those categorized as mucus components,
mucus-producing cell differentiation-related transcrip-
tion factors, mucus-producing cell differentiation-related
pathways or mediators, post-translational modification
of mucin, vesicle transport, ER stress-associated,
secretory granule-associated, mucus secretion-related
regulators and mucus hypersecretory related ion chan-
nels. While some of these 73 human small airway epi-
thelium core MUC5AC genes have been previously
associated with human airway MUC5AC expression, for
most, this is the first demonstration that, in the human
airways, these genes are coordinately up-regulated along
with MUC5AC expression. As an independent validation
set, we assessed the expression of these 73 core
MUC5AC genes in the small airway epithelium of
healthy smokers, where there is a stress on the airway
epithelium associated with up-regulation of MUC5AC
expression [1-4,17,18,22,23]. The data demonstrates that,
as in the “high” vs “low” healthy nonsmokers, the healthy
smokers up-regulate 38% of the MUC5AC-core genes.
Finally, and consistent with studies in knockout and
transgenic mice, MUC5AC expression in the human
small airway epithelium was linked to several mucus
production/secretion-related transcription factors
(SOX2, KLF4, SPDEF, XBP1 and CREB3L1), as well as
the Notch, Wnt and MAPK pathways, that, in turn, con-
trol coordinated expression of many of the MUC5AC-
core genes identified in the present study. These findings
expand the knowledge regarding molecular events
underlying human airway MUC5AC-related production/
secretion and provide several potential targets for med-
ical intervention for mucus hypersecretion.
MUC5AC expression in the human small airway
epithelium
MUC5AC is one of the major secretory mucins
expressed by surface airway epithelial cells, and repre-
sents a marker for the airway surface mucus-producing
cells [1-4,17,18,22,23]. As demonstrated in the present
study and in several other studies [25,28,29], there is
up-regulation of MUC5AC expression in the airway epi-
thelium of smokers compared to nonsmokers. This ob-
servation is consistent with the knowledge that, on the
average, smoking is associated with increased airway
mucus production [1-4,17,18,22,23]. However, novel to
the present study is the observation that MUC5AC ex-
pression in the small airway epithelium, assessed at
both the mRNA and protein levels, is highly variable
among healthy nonsmokers, implying that there are
some individuals more prone to airway mucus produc-
tion than others. We capitalized on this observation to
categorize healthy nonsmokers into “high” and “low”
MUC5AC expressors. Then, using genome wide
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“low” MUC5AC expressors to identify genes, the ex-
pression of which correlates with MUC5AC expression.
Using the literature to identify genes already known to
be associated with the airway epithelium (mostly from
murine studies), as well as to identify genes associated
with mucin expression in other organs, we were able to
define “MUC5AC-core” genes i.e., the genes plausibly
linked to MUC5AC gene expression in the human small
airway epithelium. To test the validity of the MUC5AC-
core genes, we hypothesized that many of these
genes would be up-regulated further in the small
airway epithelium of smokers, since smokers have, on
the average, up-regulation of MUC5AC. This proved to
be correct.
Mucus-producing cell differentiation-related transcription
factors, pathways and mediators
Studies of MUC5AC expression in experimental non-
human models have identified several transcription fac-
tors that modulate mucus-producing cell differentiation,
including Stat6, Spdef, Klf4, Sox2 and Foxa2
[4,5,20,31,35]. In addition to these transcription factors,
murine studies have identified several signaling path-
ways, including Wnt [6], Notch [7,8] and MAPK [9]
pathways, which have been implicated in differentiation
of MUC5AC-producing cells.
Consistent with these observations, the MUC5AC-
core genes linked to MUC5AC expression in the human
small airway epithelium in the present study include the
mucus-producing cell differentiation-related transcrip-
tion factors, SPDEF, KLF4, SOX2 and FOXA3. Up-
regulation of FOXA3 and SPDEF have been reported
during mucus overproduction in human airways cells
in vitro and in vivo [4]. SPDEF can also drive differenti-
ation of MUC5AC-producing cells in primary human
airway epithelial cells in vitro [4]. The demonstration
that SOX2 and KLF4 are linked to MUC5AC in the
human airway epithelium is novel to the present study.
The MUC5AC-core genes also included the Wnt path-
way gene LRRFIP2, Notch pathway genes HES1 and
TSTA3 [19], and the MAPK pathways genes MAPK13,
KRAS [36], and RPS6KA3 (RSK2) [37] as linked to
MUC5AC expression in the human small airway epithe-
lium. Together, this suggests that a gene network, in-
stead of single gene or pathway, controls differentiation
of MUC5AC-producting cells.
The EGF receptor family mediated signaling pathway
is involved in mucus production [32]. One of the EGF
receptor family members, ERBB2, has been shown to be
overexpressed in lung mucinous adenocarcinomas
[33,34]. However, no correlation between ERBB2 and
MUC5AC at transcription level was found in the current
study using normal airway epithelium. These resultssuggest that MUC5AC expression is not dependent on
the expression level of EGF receptors in the normal air-
way epithelium. Instead, activation status of EGF recep-
tors might be more important, while in mucinous
adenocarcinomas, the constitutive activation of the
ERBB2 pathway, which is caused by persistent up-
regulation of ERBB2 and ERBB2 mutations, might con-
tribute to the MUC5AC overexpression.
In addition to these transcription factors and path-
ways, it is known that several enzyme-related genes can
mediate mucus-producing cell differentiation [38-40].
Consistent with these observations, we found that SER-
PINB4 (serpin peptidase inhibitor), CTSC (peptidase)
and PLA2G4A (phospholipase) are up-regulated in high
MUC5AC expressors. Serpinb3a (SERPINB4 homolog)
deletion markedly attenuates mucus-producing cell
hyperplasia in mouse airway after allergen challenge
[38]; ozone and Staphylococcal enterotoxin B exposure
is associated with CTSC-driven mucus production in the
mouse [39]; and PLA2G4A activation is associated with
mucus overproduction in murine airway [40]. Both SER-
PINB4 and CTSC are up-regulated in IL13 treated
human primary bronchial epithelial cells on air liquid
interface culture [16], and PLA2G4A is more active in
bronchial explants from individuals with cystic fibrosis
[40]. It is a novel observation that these genes are linked
to small airway MUC5AC production/secretion in
healthy humans.
MUC5AC biosynthesis
MUC5AC is a polymeric mucin which is heavily glycosy-
lated and thus the ER and Golgi apparatus play a central
role in biosynthesis of MUC5AC. To form the mature
MUC5AC protein, a stepwise posttranslational modifica-
tion is needed, including N-glycosylation, dimer formation,
O-glycosylation, fucose/sialic acid/sulfate modification and
polymer formation, processes involving several specific
enzymes [2,3]. Among these, several were identified among
the MUC5AC core genes.
Consistent with the findings from mouse or human
in vitro studies, we found that AGR2 (protein disulfide iso-
merases) [41], GALNT4 and GALNT7 (GalNAc-T mem-
bers) [4] and GNE (required for normal sialylation) [42]
were up-regulated in high-MUC5AC expressors. Besides
these genes, we found some novel enzyme genes that are
likely involved in human MUC5AC posttranslational modi-
fications, including PDIA5 (disulfide isomerase), GALNT5,
GALNT6 and GALNT12 (GalNAc-T members), FUT3
and FUT6 (fucosyltransferase), ST6GAL1 and ST8SIA1
(sialic acid transferase). Interestingly, PDIA5 is also up-
regulated in Barrett’s esophagus, a disorder in which
mucus-producing cells are a basic pathologic change [43].
Along the secretory pathway, vesicle-mediated trans-
portation is important to carry newly synthesized
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function of the ER, reverse transportation is also active,
which balances the loss of protein embedded in the vesi-
cles from the ER [44]. Consistent with this concept, we
found 15 vesicle transport related genes associated with
high MUC5AC expression, including MIA3, SURF4,
KDELR2, KDELR3, ITSN1, ERGIC1, CKAP4, GOSR1,
SYNJ2BP, MPPE1, SEC31A, ARF4, VPS13D, SEC22B,
and TPD52. None have been associated with mucus pro-
duction in the literature.
Mucin biosynthesis places a large metabolic burden on
the cell, with potential ER and Golgi apparatus stress
[45]. In agreement with the concept that mucus deregu-
lation might induce ER stress, EIF2AK3 and XBP1 (clas-
sical unfolded protein response genes), EDEM3
(endoplasmic reticulum-associated degradation gene),
and CREB3L1 (non-canonic unfolded protein response
gene) were up-regulated in high-MUC5AC expressors.
EIF2AK3 can repress global protein synthesis [46], XBP1
can induce chaperone synthesis [47], and EDEM3 can
promote the degradation of poor-quality proteins [48].
Finally, the Drosophila ortholog of CREB3L1, CrebA,
has been shown to be the major and direct regulator of
secretory capacity in the salivary gland [49]. Our findings
raise the possibility that the human airway surface
MUC5AC-producing cells likely use an ER stress-asso-
ciated signal as feedback to finely control mucus
production.
MUC5AC secretion
MUC5AC secretion is highly regulated [17]. As shown
in the “secretory granule-associated” and “mucus
secretion-related regulator” categories, activation of the
mechanisms underlying mucin secretion was reflected in
the function of MUC5AC-core genes. For example, we
found PRSS23, PLCE, PRKCD, DKGA, ITPR3, RAB3D,
RAB27B, MYO5B, MYO5C, SYTL2, SYTL4, SYTL5,
SCIN, CDC42EP5, ATP6V0A4, STXBP6, PAM, RIMS1,
PLCO and CASK were up-regulated in high-MUC5AC
expressors. PRSS23 is a serine protease, which can
stimulate mucus glycoprotein release from hamster tra-
cheal ring organ culture [50]. PLCE is a PLC family
member that might be involved in generating the intra-
cellular second messengers, IP3 and DAG, in mucus-
producing cells [1]. ITPR3 is the receptor of IP3 [1].
PRKCD is a protein kinase C family member. RAB3D
and RAB27B belong to RAB3 and RAB27 family, re-
spectively [17]. ATP6V0A4 and PAM are associated with
maturation of secretion granules [51]. Both MYO5B and
MYO5C are type V myosins, and SYTL2 (SLP2A) [52],
SYTL4 and SYTL5 are granulophilins [17]. KIF5B is
associated with granule movement [53]. SCIN (scin-
derin) is an enzyme that is needed for actin disruption
[17] and gelsolin can affect actin remodeling [54].RIMS1 (RIM), PCLO (Piccolo), and CASK can help
secretory granule tethering and docking [17]. STXBP6
belongs to Munc18 family. Among this group of
MUC5AC-core genes, SYTL4, SYTL5, RIMS1, PCLO,
CASK, KIF5B, CDC42EP5, ATP6V0A4, STXBP6, PAM,
DKGA, and PLCE have not been previously identified in
association with mucus-producing cells.
Mucus hypersecretion-related ion channels
Several studies have suggested that ion channels are
involved in mucus production, including CFTR [55],
SLC26A4 (pendrin) [56], SCNN1B (ENaC subunit) [21],
CLCA family [57], GABAergic system receptors [58] and
SLC12A2 [59]. In the current study, we found SCNN1A
(ENaC alpha subunit), CLCA2 (CLCA family member),
GABAP (a subunit of the GABAergic system receptor),
SLC12A2 (Slc12a2 homolog) were up-regulated in high
MUC5AC expressors. Among them, SLC12A2 expres-
sion is known to be restricted to human airway mucus-
producing cells [59]. The links between SCNN1A,
CLCA2, GABAP and MUC5AC expression in human
airway are novel. Since multiple ion channel genes are
found to be associated with MUC5AC expression, these
observations suggest an active water/ion exchange in the
airway epithelial cell membrane during human airway
mucus production.
Several limitations of this study should be pointed out.
First, all MUC5AC-core genes were identified based on
the literature, and thus, important genes might be
ignored because we are lacking clues from current
knowledge. Second, our strategy was based on the tran-
scriptome level, so regulation mechanisms depending on
protein level modulation are underestimated.
Methods
Nomenclature
The terminology associated with mucus-producing cells
in the airway epithelium varies in the literature, includ-
ing the terms “goblet cells” and “mucous cells” [1,23].
Since we are focusing on genes correlating with the ex-
pression of MUC5AC, to avoid confusion, we use the
term “MUC5AC-producing cells” as the surface airway
epithelium cells (the cells that are sampled with bron-
choscopy and brushing) expressing MUC5AC. When re-
ferring to the literature, if the mucus-related gene/
protein is not clear, the term “mucus-producing cells”
will be used.
Ethics statement
All individuals were evaluated at the Weill Cornell NIH
Clinical and Translational Science Center and Depart-
ment of Genetic Medicine Clinical Research Facility,
using Institutional Review Board-approved clinical
protocols.
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Healthy nonsmokers and healthy smokers were recruited
from the general population in New York City. The
nonsmokers were used as the “test” set to identify the
MUC5AC-core genes; the smokers were used as a
“validation” set to determine if the MUC5AC-core genes
correlate with MUC5AC gene expression under condi-
tions (smoking) where MUC5AC gene expression is
known to be up-regulated.
The criteria for “healthy” was based on a history, phys-
ical exam, complete blood count, coagulation studies, liver
function tests, urine studies, chest X-ray, EKG and pul-
monary function tests (Table 3; see Supplemental Meth-
ods for inclusion/exclusion criteria). All subjects were
negative for HIV1 and had normal α1-antitrypsin levels.
Urine nicotine and cotinine levels were measured using li-






Gender (male/female) 38/22 51/21
Age 41± 12 43 ± 8
Race (B/W/O)2 27/23/10 45/16/11
Smoking history (pack-yr) 0 27 ± 16
Urine nicotine (ng/ml) negative 1098 ± 1312
Urine cotinine (ng/ml) negative 1228 ± 939
Pulmonary function parameters4
FVC (% predicted) 106 ± 13 110 ± 14
FEV1 (% predicted) 106 ± 14 110 ± 15
FEV1/FVC (% observed) 82 ± 6 81 ± 4
TLC (% predicted) 99 ± 13 100 ± 12
DLCO (% predicted) 98 ± 14 94 ± 11
Epithelial cells4
Number recovered x106 6.5 ± 2.9 7.4 ± 3.3
% epithelial cells5 99.1 ± 1.2 99.0 ± 1.3
% inflammatory cells 0.9 ± 1.2 1.0 ± 1.3
Differential cell count6
Ciliated (%) 72.0 ± 8.9 64.0 ± 12
Secretory (%) 6.7 ± 3.7 8.4 ± 4.4
Basal (%) 12.6 ± 6.6 14.5 ± 8.0
Intermediate (%) 7.8 ± 3.4 12.2 ± 6.8
1 Data are presented as mean ± standard deviation.
2 B = Black, W=White, O=Other.
3 Pulmonary function testing parameters are given as % of predicted value
with the exception of FEV1/FVC, which is reported as % observed; FVC - forced
vital capacity; FEV1 - forced expiratory volume in 1 sec; TLC - total lung
capacity; DLCO - diffusing capacity.
4 To quantify the percentage of epithelial and inflammatory cells and the
proportions of ciliated, basal, secretory, and intermediate epithelial cells,
aliquots of 2x104 cells were prepared by centrifugation and stained with
DiffQuik.
5 Of total cells recovered.
6 Of total epithelial cells recovered.laboratories, Salt Lake City, UT). “Nonsmokers” (n = 60)
were defined as self-reported life-long nonsmokers, with
non-detectable urine nicotine (<2 ng/ml) and cotinine
(<5 ng/ml); “Smokers” (n = 72) were defined as self-
reported current smokers with urine nicotine >2 ng/ml
and/or urine cotinine >5 ng/ml. No individuals smoked
within 12 hr prior to the bronchoscopy procedure to col-
lect the airway epithelium.
Epithelial sampling, cDNA preparation and microarray
processing
Airway epithelium (10th to12th order) was collected by
fiberoptic bronchoscopy by brushing as previously
described [14]. The expression of genes encoding surfac-
tant and Clara cell secretory proteins confirmed the
samples were derived from the small airway epithelium
[14]. Cytopreparations were prepared by centrifugation
(Cytospin 11, Shandon Instruments, Pittsburgh, PA) and
stained with Diff-Quik (Dade Behring, Newark, NJ). For
MUC5AC staining in small airway epithelium, cytospin
slides of brushed cells were stained with mouse anti-
human MUC5AC antibody (Vector, Burlingame, CA)
and detected by Cy3 labeled goat anti-mouse antibody
(Jackson, West Grove, PA). Nuclei were counterstained
with DAPI (Invitrogen, Carlsbad, CA).
RNA in the airway epithelium samples was processed for
microarray analysis as previously described [14,60]. Total
RNA was extracted from the small airway epithelium using
a modification of the TRIzol method (Invitrogen, Carlsbad,
CA) and processed to generate cDNA. Genome-wide gene
expression analysis was performed using HG-U133 Plus 2.0
array (Affymetrix, Santa Clara, CA) according to Affymetrix
protocols, hardware and software. Overall microarray qual-
ity was verified by the criteria: (1) 3'/5' ratio for GAPDH
≤3; and (2) scaling factor ≤10.0 [61]. The captured image
data from the HG-U133 Plus 2.0 arrays was processed
using the MAS5 algorithm. The raw data are available at
the Gene Expression Omnibus (GEO) site (http://www.
ncbi.nlm.nih.gov/geo/); accession number for this dataset is
GSE34450.
Mucin gene expression in the small airway epithelium
The mucin genes represented on the HG-U133 Plus 2.0
array were grouped as: secretion-nonpolymeric; secretion-
polymeric; tethered-shed in mucus; and tethered [2,3]. For
genes with multiple probe sets, the one with highest expres-
sion level in nonsmokers was chosen. The percentage of
Affymetrix “P call” was calculated for each probeset. To
compare expression levels among mucin genes, Genespring
data normalized “per chip” (normalized to the median of all
the genes on the same chip) was used.
To evaluate the expression variability of MUC5AC, en-
dogenous controls were used as references. Five en-
dogenous control genes were randomly selected from
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with “per chip” normalized gene expression level >99%
genes (probesets) on the HG-U133 Plus 2.0 array. Coef-
ficient of variation (CV) of expression of MUC5AC and
the control genes were calculated. For control genes with
multiple probesets, the one with the highest CV was
chosen. Genespring “per chip” and “per gene” (normalized
to the median of the same gene across all samples) nor-
malizations were used. Comparison of the variance of
MUC5AC vs control gene expression (“per chip” and “per
gene” normalized data) was done using the Ansari-Bradley
test in R language (http://www.r-project.org/).
Identification of MUC5AC-associated core genes
To identify the MUC5AC-associated core genes,
MUC5AC expression of the healthy nonsmokers was
quantified using probeset 214385_s_at, the probeset
generating the strongest signal among the 3 of
MUC5AC probesets on the microarray. Healthy non-
smokers were categorized as high MUC5AC expres-
sors (MUC5AC expression highest quartile, n = 15),
medium MUC5AC expressors (the 2nd and 3rd quar-
tiles; n = 15 and n = 15, respectively) and low
MUC5AC expressors (MUC5AC expression lowest
quartile, n = 15). Genome-wide analysis of the genes
associated with high and low MUC5AC expressors
were filtered by the criteria: (1) Affymetrix “P call”
>80% in nonsmokers; and (2) genes with known
annotations. Significant differences of gene expres-
sion between high MUC5AC expressors and low
MUC5AC expressors were determined by an unequal
variance Student’s t-test followed by Benjamini-
Hochberg correction (B-H correction, p< 0.05). The
probe sets of MUC5AC were not included. For genes
represented by more than one probeset, the probeset
with the lowest p value was used. The Database for
Annotation, Visualization and Integrated Discovery
(DAVID) was used to do gene function annotation
term enrichment analysis of the significant up-
regulated genes [63].The role of each up-regulated
gene in mucus production and secretion was
assessed by manual literature mining. Genes with lit-
erature supporting roles in mucus production or se-
cretion were defined as the “MUC5AC-core genes”
(see Supplemental methods for complete criteria).
Effects of smoking on expression of MUC5AC and
MUC5AC-core genes
As a validation cohort to assess the role of smoking
on MUC5AC expression and the MUC5AC-core
genes, MUC5AC expression (probeset 214385_s_at)
was compared in the small airway epithelium of
healthy nonsmokers (n = 60) and healthy smokers
(n = 72). The comparison of variability of MUC5ACto the 5 housekeeping genes in smokers was analyzed
with the Ansari-Bradley test. To determine if the
MUC5AC-core genes identified in nonsmokers were
also up-regulated in smokers, genome-wide transcrip-
tome comparison between healthy smokers (n = 72)
and healthy nonsmokers (n = 60) was based on the fil-
tered probesets (using same filter criteria used to
identify the MUC5AC-associated core genes). Signifi-
cant differences of gene expression between smokers
and nonsmokers were determined by an unequal vari-
ance Student’s t-test followed by Benjamini-Hochberg
correction (p<0.05). The results of MUC5AC-core
genes (fold-change and Benjamini-Hochberg corrected
p value) were then extracted.
Cluster analysis was performed on microarray data (“per
chip” and “per gene” normalization) of the MUC5AC-core
genes in nonsmokers and smokers using settings with
Spearman correlation as similarity measure and the
average linkage clustering algorithm. To reduce the vari-
ability associated with medium MUC5AC expressors, only
nonsmoker-high MUC5AC expressors (highest quartile
of all healthy nonsmokers, n = 15), nonsmoker-low
MUC5AC expressors (lowest quartile of all healthy non-
smokers, n = 15), smoker-high MUC5AC expressors (high-
est quartile of all healthy smokers, n = 18) and smoker-low
MUC5AC expressors (lowest quartile of all healthy smo-
kers, n = 18) were used.
Asthma study
GEO4302 datasets [30] were used to evaluate the ef-
fect of asthma on MUC5AC-core genes, using data
from 42 asthmatics and 28 healthy subjects in this
data set. Microarray data were processed by RMA al-
gorithm in Genespring 7.0. Significant differences of
gene expression between asthma and healthy subjects
were determined by an unequal variance Student’s t-
test followed by Benjamini-Hochberg correction (p
< 0.05). Genome-wide correlations to MUC5AC
(214385_s_at) were assessed by Spearman’s rank cor-
relation coefficient.
MUC5AC-core gene index
A “MUC5AC-core gene index” was created as a glo-
bal measure of the coordinate MUC5AC-enhanced
expression-associated changes by integrating infor-
mation on expression levels of all MUC5AC-core
genes using the conceptual framework described by
Tilley et al. [64]. For each gene, the mean and
standard deviation were calculated from the values
in nonsmoker-low MUC5AC expressors. The “nor-
mal range” was defined as within 2 standard devia-
tions (SD) of the mean. The MUC5AC-core gene
index for each nonsmoker and smoker was defined
as a percentage of MUC5AC-core genes with
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where E1 has a value of 1 if the expression level for
gene 1 was >2 SD beyond that of nonsmoker-low
MUC5AC expressors or a value of 0 if the expres-
sion level was ≤2 SD below that of nonsmoker-low
MUC5AC expressors; E2 is the index for gene 2,
etc., and the constant c [c = 100 divided by the num-
ber of MUC5AC-core genes (n) normalizes the index
to the percent of MUC5AC-core genes that are out-
side of the range of healthy nonsmoker-low expres-
sors]. The statistical significance of differences in
index between the groups was determined using the
Mann Whitney U-test.
RNA-seq data analysis
Analysis of the MUC5AC-core genes was also carried out
using a database of massive parallel sequencing (RNA-
Seq) of the transcriptome of healthy nonsmokers (n= 5)
and healthy smokers (n= 6) [65]. Because there is no
MUC5AC sequence in the reference genome build UCSC
hg19, the resultant reads were aligned to Homo sapiens
high coverage assembly GRCh37 using Bowtie v 0.12.
Reads per kilobase of exon model per million mapped
reads (RPKM) was used to quantify transcript levels of
each gene. The sequence read data have been submitted
to the NCBI SRA database (SRA accession #SRP005411).
Of the 73 MUC5AC-core genes, 72 were used for cluster-
ing analysis (GALNT4 does not have an ensembl se-
quence). Log2 transformed gene level RNA-Seq data was
used for hierarchical clustering analysis, which was
performed in “HierarchicalClustering” of Genepattern
(http://genepattern.broadinstitute.org) with the default set-
ting (Distance measure: Pearson correlation; Clustering
method: pairwise complete-linkage). To visualize the heat-
map, “HierarchicalClusteringViewer” of Genepattern was
used with the default setting (View Options are “relative
color schemes” and “gradient color”).
Gene network analysis
A gene network analysis was built on the human small
airway epithelium MUC5AC-core genes by manually
data mining the literature. The network focused on tran-
scription control, using transcription factors/pathways
known to be associated with mucin biosynthesis (SPDEF,
SOX2 and KLF4 and Wnt, Notch and MAPK pathways)
as the network backbone. MUC5AC-core genes with
transcriptional/pathway level connections with other
MUC5AC-core genes were selected to expand the net-
work. The interconnections among genes were based onliterature with gene overexpression/activation/knock-
down experiments in vitro or data from genetically engi-
neered mice showing that the expression level of one
gene is affected by another gene. Protein-protein interac-
tions were not included (See Additional file 1: Table S5
for details).
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